Seoul National University Hospital Opens Global R&D Hub Center in Boston...K-Bio Accelerates Global Entry
Apr 15, 2025
Seoul National University Hospital opened 'Seoul National University Hospital's Global R&D Hub Center (Boston Office)' in Boston, USA on the 14th (local time).
It plans to promote global research cooperation and technology commercialization strategies in the field of advanced bio.
The opening of Seoul National University Hospital is the first global base specialized in high-tech bio research and technology commercialization, and is expected to be an important turning point in accelerating K-bio's global expansion.
Boston Office is the third office opened in the United States after LA Office (2008) and New York Office (2012), where Seoul National University Hospital performed medical support functions, but it is significant in that it is the first global base specializing in R&D and technology commercialization. Boston Office is located in Boston's Cambridge Innovation Center (CIC Cambridge), the world's largest bio cluster, and is located in an area where more than 1,000 bio and pharmaceutical companies, including Moderna and Pfizer, and global research institutes such as MIT, Harvard University, and Massachusetts General Hospital are concentrated. Seoul National University Hospital plans to further accelerate global research cooperation and technology commercialization by utilizing the region.
The Boston Office is part of the Department of Health and Human Services' specialized laboratory project and plays an important role as a 'triangle hub' connecting research, industry, and talent. Through this, △ Analysis of global high-tech bio industry trends and discovery of new research and business opportunities △ Discovery of international joint research projects with Harvard Medical School, MIT, Stanford, etc. △ Support for training next-generation doctor scientists and key research personnel △ Establishment of strategies for commercializing promising technologies in Korea, discovery of early bio startups, and support linkage with local investment will lead the globalization of K-bio.
In particular, the Boston Office will strengthen global research cooperation on various key challenges underway at specialized labs and quickly establish a commercialization strategy through field research and networking. In addition, it plans to create synergy through connection with Boston Korea's joint research support project and cooperate with the network of Korean researchers in Boston to provide opportunities to discover next-generation talents and incorporate global advanced biotechnology trends into domestic research and industry.
On April 13, a day before the opening of the Boston Office, Kim Young-tae held a meeting with professors and students working at leading Boston institutions, emphasizing that the Boston Office will support the growth of medical scientists who will lead the country's future. Hospital President Kim Young-tae, Medical Life Research Institute President Kim Yong-jin, Planning and Coordination Director Cho Young-min, and Foreign Cooperation Director Park Do-joong attended the opening ceremony on the 14th to celebrate the start of the Boston Office by attaching a signboard.
Hospital Director Kim Young-tae said, `The opening of Boston Office will be an important stepping stone to accelerate the global expansion of K-bio.' We will do our best to contribute to the development of Korea's high-tech bio industry by developing commercialization strategies in cooperation with the National Institute of Strategic Technology, domestic and foreign joint researchers, and domestic companies."
It plans to promote global research cooperation and technology commercialization strategies in the field of advanced bio.
The opening of Seoul National University Hospital is the first global base specialized in high-tech bio research and technology commercialization, and is expected to be an important turning point in accelerating K-bio's global expansion.
Boston Office is the third office opened in the United States after LA Office (2008) and New York Office (2012), where Seoul National University Hospital performed medical support functions, but it is significant in that it is the first global base specializing in R&D and technology commercialization. Boston Office is located in Boston's Cambridge Innovation Center (CIC Cambridge), the world's largest bio cluster, and is located in an area where more than 1,000 bio and pharmaceutical companies, including Moderna and Pfizer, and global research institutes such as MIT, Harvard University, and Massachusetts General Hospital are concentrated. Seoul National University Hospital plans to further accelerate global research cooperation and technology commercialization by utilizing the region.
The Boston Office is part of the Department of Health and Human Services' specialized laboratory project and plays an important role as a 'triangle hub' connecting research, industry, and talent. Through this, △ Analysis of global high-tech bio industry trends and discovery of new research and business opportunities △ Discovery of international joint research projects with Harvard Medical School, MIT, Stanford, etc. △ Support for training next-generation doctor scientists and key research personnel △ Establishment of strategies for commercializing promising technologies in Korea, discovery of early bio startups, and support linkage with local investment will lead the globalization of K-bio.
In particular, the Boston Office will strengthen global research cooperation on various key challenges underway at specialized labs and quickly establish a commercialization strategy through field research and networking. In addition, it plans to create synergy through connection with Boston Korea's joint research support project and cooperate with the network of Korean researchers in Boston to provide opportunities to discover next-generation talents and incorporate global advanced biotechnology trends into domestic research and industry.
On April 13, a day before the opening of the Boston Office, Kim Young-tae held a meeting with professors and students working at leading Boston institutions, emphasizing that the Boston Office will support the growth of medical scientists who will lead the country's future. Hospital President Kim Young-tae, Medical Life Research Institute President Kim Yong-jin, Planning and Coordination Director Cho Young-min, and Foreign Cooperation Director Park Do-joong attended the opening ceremony on the 14th to celebrate the start of the Boston Office by attaching a signboard.
Hospital Director Kim Young-tae said, `The opening of Boston Office will be an important stepping stone to accelerate the global expansion of K-bio.' We will do our best to contribute to the development of Korea's high-tech bio industry by developing commercialization strategies in cooperation with the National Institute of Strategic Technology, domestic and foreign joint researchers, and domestic companies."
|
This article was translated by Naver AI translator.
